Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
HUN Quote, Financials, Valuation and Earnings
Last price:
$11.32
Seasonality move
:
4.49%
Day range:
$10.74 - $11.35
52-week range:
$10.13 - $25.12
Dividend yield:
8.85%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
0.67x
Volume:
4.8M
Avg. volume:
4M
1-year change:
-52.26%
Market cap:
$2B
Revenue:
$6B
EPS (TTM):
-$0.91
Analysts' Opinion
-
Consensus RatingHuntsman has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 12 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $13.12, Huntsman has an estimated upside of 16.07% from its current price of $11.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 2.66% downside risk from its current price of $11.30.
Fair Value
-
According to the consensus of 14 analysts, Huntsman has 16.07% upside to fair value with a price target of $13.12 per share.
HUN vs. S&P 500
-
Over the past 5 trading days, Huntsman has underperformed the S&P 500 by -2.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Huntsman does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Huntsman revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Huntsman reported revenues of $1.4B.
Earnings Growth
-
Huntsman has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Huntsman reported earnings per share of -$0.03.
Enterprise value:
3.8B
EV / Invested capital:
--
Price / LTM sales:
0.33x
EV / EBIT:
36.93x
EV / Revenue:
0.64x
PEG ratio (5yr expected):
-0.17x
EV / Free cash flow:
50.04x
Price / Operating cash flow:
25.64x
Enterprise value / EBITDA:
9.70x
Gross Profit (TTM):
$866M
Return On Assets:
-2.15%
Net Income Margin (TTM):
-2.63%
Return On Equity:
-4.78%
Return On Invested Capital:
-3.02%
Operating Margin:
0.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $7.4B | $6B | $6B | $1.5B | $1.4B | |
| Gross Profit | $1.3B | $838M | $866M | $201M | $201M | |
| Operating Income | $529M | $92M | $40M | $44M | $10M | |
| EBITDA | $819M | $352M | $392M | $52M | $115M | |
| Diluted EPS | $1.95 | -$0.52 | -$0.91 | -$0.22 | -$0.03 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $4B | $2.7B | $2.4B | $2.3B | |
| Total Assets | $8.3B | $9.4B | $7.8B | $7.6B | $7.2B | |
| Current Liabilities | $1.6B | $2.1B | $1.3B | $1.6B | $1.5B | |
| Total Liabilities | $4.6B | $4.9B | $3.8B | $4.2B | $4.1B | |
| Total Equity | $3.7B | $4.5B | $4B | $3.4B | $3.2B | |
| Total Debt | $1.6B | $1.6B | $1.5B | $2.1B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $675M | $298M | $254M | -$65M | -$74M | |
| Cash From Investing | $275M | -$214M | -$90M | -$30M | $6M | |
| Cash From Financing | -$1.1B | -$133M | -$374M | $108M | $60M | |
| Free Cash Flow | $421M | $72M | $76M | -$107M | -$110M | |
HUN
Sector
Market Cap
$2B
$19.1M
Price % of 52-Week High
44.98%
70.42%
Dividend Yield
8.85%
0%
Shareholder Yield
4.49%
0.73%
1-Year Price Total Return
-52.26%
-6.33%
Beta (5-Year)
0.706
0.736
Dividend yield:
8.85%
Annualized payout:
$1.00
Payout ratio:
-110.83%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$11.32
200-day SMA
Sell
Level
$16.59
Bollinger Bands (100)
Sell
Level
10.95 - 15.75
Chaikin Money Flow
Buy
Level
4.8M
20-day SMA
Buy
Level
$10.91
Relative Strength Index (RSI14)
Buy
Level
50.80
ADX Line
Buy
Level
24.54
Williams %R
Neutral
Level
-45.9459
50-day SMA
Sell
Level
$11.42
MACD (12, 26)
Buy
Level
3.10
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
10.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8746)
Sell
CA Score
(Annual)
Level (-0.4204)
Buy
Beneish M-Score
(Annual)
Level (-2.7538)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.711)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
Stock Forecast FAQ
In the current month, HUN has received 1 Buy ratings 12 Hold ratings, and 1 Sell ratings. The HUN average analyst price target in the past 3 months is $13.12.
-
Where Will Huntsman Stock Be In 1 Year?
According to analysts, the consensus estimate is that Huntsman share price will rise to $13.12 per share over the next 12 months.
-
What Do Analysts Say About Huntsman?
Analysts are divided on their view about Huntsman share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Huntsman is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Huntsman's Price Target?
The price target for Huntsman over the next 1-year time period is forecast to be $13.12 according to 14 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 12 analysts rate the stock a Hold.
-
Is HUN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Huntsman is a Hold. 12 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HUN?
You can purchase shares of Huntsman via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Huntsman shares.
-
What Is The Huntsman Share Price Today?
Huntsman was last trading at $11.32 per share. This represents the most recent stock quote for Huntsman. Yesterday, Huntsman closed at $11.30 per share.
-
How To Buy Huntsman Stock Online?
In order to purchase Huntsman stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
